Does the MTNR1B rs10830963 G allele impair early insulin secretion and raise glucose, especially with late eating?

The association between the MTNR1B rs10830963 G allele and impaired glucose metabolism is well-established through functional studies and clinical trials, particularly regarding its interaction with melatonin and meal timing.

Clinical and effectiveness evidence

The rs10830963 G allele is a robust genetic marker for elevated fasting plasma glucose and a significantly increased risk for type 2 diabetes (OR ~1.05–1.90 across diverse populations).

• Insulin Secretion: Research consistently shows that G-allele carriers exhibit a blunted early-phase insulin response (e.g., 30-minute C-peptide during an oral glucose tolerance test).
• Meal Timing: Randomized crossover trials have demonstrated that the metabolic impact of this variant is magnified when food is consumed close to sleep. A study comparing early dinner (4 hours before bedtime) to late dinner (1 hour before bedtime) found that late eating coincided with melatonin levels 3.5 times higher, which specifically impaired glucose tolerance and reduced insulin secretion in G-allele carriers more severely than in non-carriers.

Mechanistic explanations

The rs10830963 G allele acts as an expression quantitative trait locus (eQTL), leading to increased MTNR1B mRNA and protein levels (MT2 receptors) within pancreatic beta-cells.

• Receptor Overexpression: Higher receptor density amplifies the inhibitory signaling of melatonin. When melatonin binds to these receptors, it inhibits adenylate cyclase and reduces intracellular cAMP levels, a key secondary messenger for glucose-stimulated insulin release.
• Circadian Interaction: Because endogenous melatonin levels rise naturally in the evening and peak during sleep, the inhibitory effect on insulin is greatest during these periods. In G-allele carriers, this physiological inhibition is exaggerated, leading to postprandial hyperglycemia if glucose is introduced when melatonin levels are high.

Bottom line

The MTNR1B rs10830963 G allele directly impairs early-phase insulin secretion by increasing melatonin receptor density in the pancreas. This effect is most clinically relevant during late-night eating, where the combination of high melatonin and the risk genotype creates a unique vulnerability to glucose intolerance.